TERRILYN BLACKSTOCK: Open Payments
NPI 1740672542 · CALHOUN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$763 in 38 payments from 19 companies in 2025. Trend: 2023 $676 · 2024 $901 · 2025 $763
Food & beverage: $718Education: $45
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 8 | $169 |
| Novartis Pharmaceuticals Corporation | 3 | $72 |
| Merck Sharp & Dohme LLC | 2 | $64 |
| GENZYME CORPORATION | 3 | $60 |
| Daiichi Sankyo Inc. | 2 | $40 |
| Exelixis Inc. | 2 | $39 |
| Astellas Pharma US Inc | 1 | $33 |
| ARRAY BIOPHARMA INC | 6 | $32 |
| Coherus Oncology, Inc. | 1 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
Products named: Padcev, INLYTA, PLUVICTO, Enhertu, CABOMETYX, KEYTRUDA, TUKYSA, IBRANCE.
Industry payments across GA — which companies pay providers there.
